In a colon cancer model with a heterogeneous response to avelumab (anti-PD-L1), single-cell RNA sequencing on biopsies before treatment allowed the discovery of a Cxcl9+ macrophage subset which is associated with the response. The gene discussed is CXCL9; the disease is colonic neoplasm.